A retrospective comparative study of progression-free survival and overall survival between metachronous and synchronous metastatic renal cell carcinoma in intermediate- or poor-risk patients treated with VEGF-targeted therapy

INTRODUCTION: The aim of this study was to compare progression-free survival (PFS) and overall survival (OS) between metachronous and synchronous metastatic renal cell carcinomas treated with VEGF-targeted therapy. METHODS: Between 2005 and 2014, 93 (78.8%) intermediate- and 25 (21.2%) poor-Heng-ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sung Han, Suh, Yoon Seok, Lee, Dong-Eun, Park, Boram, Joo, Jungnam, Joung, Jae Young, Seo, Ho Kyung, Lee, Kang Hyun, Chung, Jinsoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706824/
https://www.ncbi.nlm.nih.gov/pubmed/29212178
http://dx.doi.org/10.18632/oncotarget.20674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706824/
https://www.ncbi.nlm.nih.gov/pubmed/29212178
http://dx.doi.org/10.18632/oncotarget.20674

Ejemplares similares